Arbor Vita’s OncoE6TM Cervical Test - a novel, simple and specific approach to meet challenges of worldwide screening for HPV induced cancers-Johannes Schweizer-03/25/2014 - 8:30am

Event Information
Event Topic: 
Arbor Vita’s OncoE6TM Cervical Test - a novel, simple and specific approach to meet challenges of worldwide screening for HPV induced cancers
Event Date: 
03/25/2014 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Johannes Schweizer
Event Speaker Title: 
Vice President of Research and Development
Event Speaker Company: 
Arbor Vita Corporation
Event Speaker Bio: 

Johannes Schweizer
Dr. Schweizer is Vice President of Research and Development at Arbor Vita Corporation, an emerging biotechnology company located in Fremont, CA. Dr. Schweizer has a broad education in molecular biology with a focus on genetics, epigenetic mechanism of gene regulation, virology, cellular oncology, genomic analysis and application of proteomics towards in in-vitro diagnostic and therapeutic approaches. Dr. Schweizer obtained his MS from Constance University (Germany) in molecular genetics, performed his Ph.D. work in the Department of Retrovirology at the Pasteur Institute (Paris, France), and did post doctoral studies in a Howard Hughes Medical Institute laboratory in the Department of Genetics at Stanford University. Dr. Schweizer joined Arbor Vita Corp. at inception, and he initiated a Arbor Vita’s PDZ protein based proteomic platform. He was a key contributor in the development of a Flu A/H5N1 rapid test (the first rapid proteomic test to be FDA cleared), and he was pivotal in the development of Arbor Vita’s E6/E7 oncoprotein based programs for detection and treatment of HPV induced cancers. Besides directing R&D at Arbor Vita, Dr. Schweizer is also initiating and maintaining scientific collaborations and business relationships on an international level. As an extramural activity, Dr. Schweizer serves the US National Cancer Institute as a long term reviewer of grant applications in the field of cancer diagnostics.

Event Details
Event Details: 

Worldwide, cervical cancer is a major cause of cancer related death in women, with >80% mortality occurring in developing countries. Implementation of appropriate cervical (pre-) cancer screening technology is pivotal towards reduction of this unacceptably high death toll. Arbor Vita’s OncoE6TM Cervical Test constitutes an entirely new technology concept, fulfilling major requirements of a test for developing countries: simplicity of use and high clinical specificity and positive predictive value (PPV). In the presentation, an overview on the technology concept will be provided and data from a large clinical study will be presented. Finally, ongoing and future avenues for implementation of the OncoE6TM Cervical Test in settings of need will be discussed.